Claude Nicolau

Dr. Nicolau is a Professor of Medicine at the Tufts University in Boston, U.S.A. Prof. Nicolau's main area of work is the study of membrane involvement in pharmacological processes at the molecular level. For several years, Dr. Nicolau is working on an Immunotherapy for Alzheimer's disease and other "conformational" disease. He has published more than 210 scientific papers and has been awarded 30 patents todate. Prof. Nicolau is one of the Founders of Alantos AG, Heidelberg and has been for two years CSO of that company.